Background
==========

Gastric cancer (GC) is the sixth most common form of cancer and the second most common in terms of mortality worldwide \[[@b1-medscimonit-25-1788]\]. The pathology of GC can be divided into 2 groups: cardia and non-cardia adenocarcinoma. Diagnostic and treatment strategies are advancing, yet the prognosis for GC patients remains poor \[[@b2-medscimonit-25-1788]\]. Since there is an increasing trend of the disease burden, more research is needed on identify the risk factors for GC. Numerous studies have already demonstrated that obesity, smoking, gastroesophageal reflux disease, and *Helicobacter pylori* infection are significantly associated with the risk of GC \[[@b3-medscimonit-25-1788]--[@b7-medscimonit-25-1788]\]. Moreover, fruit and vegetable consumption was associated with a reduced risk of GC, irrespective of the subsite or histologic type. An explanation for this could be that the high contents of antioxidants, phytosterols, and other substances in fruits and vegetables could inhibit carcinogenesis by free-radical quenching or blocking N-nitroso compound formation \[[@b8-medscimonit-25-1788]--[@b10-medscimonit-25-1788]\].

Ingested nitrate can convert to nitrite through the bacterial flora in the mouth and digestive tract. Moreover, nitrite levels can affect the formation of N-nitroso compounds. Endogenous nitrosation accounts for an estimated 45--75% of total N-nitroso compounds exposure \[[@b11-medscimonit-25-1788]\], and the acceptable daily intake values should be explored in the general population. Moreover, the potential impacts of nitrite and nitrate intake and subsequent risk of GC remain controversial. Therefore, we performed a comprehensive search of the available observational studies to assess the association between nitrite or nitrate intake and the risk of GC. We also assessed whether these relationships differed according to study or participant characteristics.

Material and Methods
====================

Data sources, search strategy, and selection criteria
-----------------------------------------------------

This meta-analysis was according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Statement, which published in 2009 \[[@b12-medscimonit-25-1788]\]. The study investigated the associations of nitrite or nitrate intake with the risk of GC, and no restrictions were placed on language or status of eligible publications. The PubMed, EMBASE, and the Cochrane Library databases were systematically searched in the timeframe from their inception to November 2018 for potentially eligible publications. The core search terms of (nitrate OR nitrite OR N-nitroso compounds) AND (cancer OR neoplasm OR carcinoma OR tumor) AND (gastric OR stomach) were used. The reference lists from the retrieved studies were manually searched to identify any new eligible studies. The PICOS criteria were used to identify any potential studies.

The study selection process was conducted by 2 authors, and any disagreement was resolved by the corresponding author. The inclusion criteria of this meta-analysis were as follows: (1) study designed as case-control or prospective cohort; (2) the study reported the relationship between nitrite or nitrate intake and the risk of GC incidence or mortality; and (3) the study reporting effect estimates and 95% confidence intervals (CIs) for comparisons of various categories and the lowest nitrite or nitrate intake.

Data collection and quality assessment
--------------------------------------

Data collection and quality assessment processes were performed by 2 authors and any disagreement was settled by group discussion and by an additional author referring to the original study. The collected information included the first author's surname, publication year, study design, country, sample size, age, the percentage of male patients, assessment of exposure, GC incidence or mortality, and adjusted factors. The Newcastle-Ottawa Scale (NOS), based on selection (4 stars), comparability (2 stars), and outcome (3 stars), was used to evaluate study quality, and the "star system" range was 0--9 for evaluating the quality of included studies \[[@b13-medscimonit-25-1788]\].

Statistical analysis
--------------------

The relationship between nitrite or nitrate intake and the risk of GC were examined based on the effect estimate (odds ratio \[OR\], relative risk \[RR\], or hazard ratio \[HR\]) and corresponding 95% CIs in each study. The multiple categories of nitrite or nitrate intake within a single study were summarized into high or moderate nitrite/nitrate intake using a fixed-effects model, while the pooled results across included studies were evaluated using a random-effects model \[[@b14-medscimonit-25-1788],[@b15-medscimonit-25-1788]\]. Heterogeneity test was performed using the I-square and Q statistic, and significant heterogeneity was defined as P\<0.010 \[[@b16-medscimonit-25-1788],[@b17-medscimonit-25-1788]\]. Sensitivity analyses were conducted to assess the stability of the pooled results \[[@b18-medscimonit-25-1788]\]. Subgroup analyses for high or moderate nitrite/nitrate intake and the risk of GC were conducted based on publication year, study design, country, the percentage of male patients, assessment of exposure, adjusted model, and study quality. The interaction tests between subgroups were also performed to compare whether these associations differed according to study or participant characteristics \[[@b19-medscimonit-25-1788]\]. Publication biases for high or moderate nitrite/nitrate intake and the risk of GC were evaluated using funnel plots, Egger test \[[@b20-medscimonit-25-1788]\], and Begg \[[@b21-medscimonit-25-1788]\] test. The inspective levels for pooled results are 2-sided, and p values less than 0.05 were regarded as statistically significant. Stata software was employed for all statistical analyses (version 10.0; Stata Corporation, College Station, TX, USA).

Results
=======

Literature search and study characteristics
-------------------------------------------

The initial searches of the electronic databases produced 831 articles; of these, 769 were discarded due to duplication or irrelevance. The remaining 62 studies underwent full-text evaluations; 38 of these were excluded for not assigning nitrite or nitrate as exposure markers (n=21), for reporting the sample population (n=12), or for being a systematic review (n=5). Ultimately, 18 case-control studies and 6 cohort studies were included in the final quantitative meta-analysis \[[@b22-medscimonit-25-1788]--[@b45-medscimonit-25-1788]\]. No additional eligible studies were found in the manual search of the references of retrieved studies. Details of the study selection process are presented in [Figure 1](#f1-medscimonit-25-1788){ref-type="fig"}, while the baseline characteristics of the patients included in the examined studies are shown in [Table 1](#t1-medscimonit-25-1788){ref-type="table"}.

A total of 24 studies that recruited a total of 800 321 individuals were included in this study; the publication dates ranged from 1985 to 2017. The sample sizes ranged from 220 to 494 979, and the percentage of male patients ranged from 20.0% to 78.1%. Thirteen studies were conducted in Europe, while the rest were conducted in Canada, the USA, Mexico, Korea, and India. Eighteen studies used a food-frequency questionnaire (FFQ) to assess exposure, while the remaining 6 studies used an interviewer-administered questionnaire (IAQ) to evaluate exposure. The association between nitrite intake and the risk of GC was reported in 19 studies, and the impact of nitrate intake was reported in 17 studies. NOS was used for evaluation of study quality and is shown in [Table 1](#t1-medscimonit-25-1788){ref-type="table"}. Six studies had 8 stars, 13 studies had 7 stars, and the remaining 5 studies had 6 stars.

Nitrite intake and gastric cancer
---------------------------------

The association between high nitrite intake and the risk of GC was reported in 19 studies. A high nitrite intake was associated with an increased risk of GC (OR, 1.27; 95%CI, 1.03--1.55; P=0.022; [Figure 2](#f2-medscimonit-25-1788){ref-type="fig"}), and significant heterogeneity across included studies (I-square, 89.6%; P\<0.001). A sensitivity analysis indicated that the conclusion was not altered by excluding any particular study (data not shown). Subgroup analyses suggested the significantly increased GC risk mainly included pooled studies published in or after 2000 (OR, 1.28; 95%CI, 1.09--1.51; P=0.003), studies designed as case-control (OR, 1.38; 95%CI, 1.02--1.85; P=0.034), studies conducted in other countries (OR, 1.56; 95%CI, 1.32--1.84; P\<0.001), studies with a percentage of male patients \<60.0% (OR, 1.18; 95%CI, 1.01--1.37; P=0.032), studies using an IAQ to assess exposure (OR, 1.73; 95%CI, 1.22--2.44; P=0.002), studies with partial adjustment (OR, 1.47; 95%CI, 1.20--1.79; P\<0.001), and studies of high quality (OR, 1.36; 95%CI, 1.18--1.56; P\<0.001). Moreover, we assessed whether publication year, country, the percentage of male patients, assessment of exposure, adjusted extent, and study quality could bias the correlation between high nitrite intake and the risk of GC ([Table 2](#t2-medscimonit-25-1788){ref-type="table"}). We found no significant publication bias for high nitrite intake and GC risk (P for Egger=0.061; P for Begg=0.576).

An association between moderate nitrite intake and the risk of GC was reported in 15 studies. The pooled OR indicated that moderate nitrite intake produced additional risk for GC risk by 12% (OR, 1.12; 95%CI, 1.01--1.26; P=0.037; [Figure 3](#f3-medscimonit-25-1788){ref-type="fig"}), and significant heterogeneity was detected (I-square, 63.9%; P\<0.001). Sensitivity analyses indicated that the pooled results changed after the exclusion of several studies due to marginal 95%CI (data not shown). The subgroup analysis upon pooling of the case-control studies (OR, 1.23; 95%CI, 1.07--1.43; P=0.005), the studies conducted in other countries (OR, 1.30; 95%CI, 1.01--1.67; P=0.045), studies with a percentage of male patients ≥60.0% (OR, 1.43; 95%CI, 1.16--1.77; P=0.001), studies using IAQ to assess exposure (OR, 1.56; 95%CI, 1.27--1.93; P\<0.001), studies with partial adjustment (OR, 1.20; 95%CI, 1.02--1.40; P=0.025), and studies of high quality (OR, 1.13; 95%CI, 1.00--1.27; P=0.044) indicated that moderate nitrite intake increases the risk of GC. Study design, country, the percentage of male patients, and assessment of exposure played an important role in the correlation between moderate nitrite intake and GC risk ([Table 2](#t2-medscimonit-25-1788){ref-type="table"}). No significant publication bias was observed (P for Egger, 0.115; P for Begg, 0.692).

Nitrate intake and gastric cancer
---------------------------------

The association between high nitrate intake and the risk of GC was reported in 17 studies. The summary OR indicated that a high nitrate intake plays a protective role on the progression of GC (OR, 0.81; 95%CI, 0.68--0.97; P=0.021; [Figure 4](#f4-medscimonit-25-1788){ref-type="fig"}), and showed significant heterogeneity across the included studies (I-square, 76.3%; P\<0.001). A sensitivity analysis found the conclusion was stable and not changed by excluding individual studies (data not shown). Subgroup analyses indicated that high nitrate intake was associated with decreased risk of GC in studies published before 2000 (OR, 0.75; 95%CI, 0.60--0.93; P=0.010), those conducted in Europe (OR, 0.78; 95%CI, 0.64--0.95; P=0.015), those that used FFQ to assess exposure (OR, 0.75; 95%CI, 0.64--0.88; P\<0.001), and those of high quality (OR, 0.75; 95%CI, 0.63--0.89; P=0.001). Moreover, publication year, country, the percentage of male patients, assessment of exposure, adjustment extent, and study quality could bias the correlation between high nitrate intake and GC ([Table 2](#t2-medscimonit-25-1788){ref-type="table"}). There was no publication bias among included studies (P for Egger, 0.054; P for Begg, 0.343).

The association between moderate nitrate intake and the risk of GC was reported in 15 studies. We noted that a moderate nitrate intake was associated with a decreased risk of GC (OR, 0.86; 95%CI, 0.75--0.99; P=0.036; [Figure 5](#f5-medscimonit-25-1788){ref-type="fig"}), and significant heterogeneity was noted (I-square, 67.6%; P\<0.001). The pooled results were variable after the sequential exclusion of individual studies due to marginal 95%CI (data not shown). The subgroup analyses indicated that the risk of GC was decreased in the moderate versus the lowest nitrate intake when studies were conducted before 2000 (OR, 0.80; 95%CI, 0.65--0.98; P=0.032), studies had a case-control design (OR, 0.80; 95%CI, 0.66--0.96; P=0.018), studies conducted in Europe (OR, 0.81; 95%CI, 0.70--0.94; P=0.006), studies that used FFQ to assess exposure (OR, 0.85; 95%CI, 0.74--0.99; P=0.037), and studies with partial adjustment (OR, 0.83; 95%CI, 0.74--0.93; P=0.002). Moreover, publication year, study design, and country played an important role in the correlation between moderate nitrate intake and the risk of GC ([Table 2](#t2-medscimonit-25-1788){ref-type="table"}). No evidence of publication bias was observed by using Egger and Begg tests (P for Egger, 0.323; P for Begg, 0.921).

Discussion
==========

This comprehensive quantitative meta-analysis aimed to assess any potential associations between nitrite or nitrate intake and subsequent GC risk based on all available observational studies. The current study included 800 321 individuals from 18 case-control and 6 cohort studies with a wide range of participant characteristics. Overall, a high or moderate nitrite intake was associated with an increased risk of GC. Conversely, a high or moderate nitrate intake provides a protective effect against GC. The summary results for moderate nitrite or nitrate intake on the risk of GC were variable and therefore require further large-scale studies for verification. Moreover, these associations differed when stratified by publication year, study design, country, the percentage of male patients, assessment of exposure, adjusted model, and study quality.

The study conducted by Xie et al. contained 62 observational studies and found dietary nitrate intake was inversely associated with the risk of GC, whereas dietary nitrite intake did not yield a significant association with the risk of GC \[[@b46-medscimonit-25-1788]\]. However, the study compared only the highest versus lowest dietary nitrate or nitrite intake, while the effect estimates at various medium exposures were not included; this may result in the oversight of several important datapoints for these associations. Moreover, several additional studies should be updated in this study. Therefore, the current study aimed to systematically evaluate the potential role of nitrite and nitrate intake in the risk of GC.

The summary results indicated that a high or moderate nitrite intake was associated with an increased risk of GC. Most of the included studies reported a positive trend between high or moderate nitrite intake and the risk of GC, while several studies reported reverse trend. Pobel et al. indicated that nitrite and nitrate intakes were not correlated with the risk of GC, and speculated that this could be due to the contribution of vegetables and fruits to dietary nitrite \[[@b27-medscimonit-25-1788]\]. De Stefani et al. found that high nitrite intake produced a protective effect on GC risk, which could be due to exogenous N-nitroso compounds contributing to a similar role in the risk of GC \[[@b31-medscimonit-25-1788]\]. This study indicated that a high or moderate nitrite intake was correlated with a higher risk of GC; the reason for this was correlated with the sources of nitrite intake, and nitrite from animal products play an important role on endogenous nitrosation \[[@b47-medscimonit-25-1788]\].

We noted that high or moderate nitrate intakes are correlated with a reduced risk of GC than the lowest nitrate intake. Taneja et al. indicated that the intake of \>45 mg/L nitrate via drinking water produced an additional GC risk \[[@b45-medscimonit-25-1788]\]. The potential reason for this could be the source of nitrate. In this study, the nitrate source in most of the included studies was vegetables that contain nutrients that inhibit the N-nitrosation in food, and the beneficial effects of nitrate intake could be affected by vitamin C and other antioxidants \[[@b48-medscimonit-25-1788]\]. Vitamins C and E could inhibit endogenous nitrosation and hinder the formation of nitrosation compounds \[[@b49-medscimonit-25-1788]\].

Subgroup analyses indicated that publication year, study design, country, the percentage of male patients, assessment of exposure, adjusted model, and study quality could bias the correlation between nitrite or nitrate intake and the risk of GC. First, the diagnosing strategy and timing were developed through the study publication year. Second, the current study included case-control and cohort studies, which associated with the evidence level. Third, the percentage of male patients contributed to the heterogeneity of the associations, possibly due to the different prevalence of GC between men and women. Fourth, the assessment of exposure was correlated with the accuracy of data collection. Fifth, the extent of adjustment could affect the intrinsic association of nitrite or nitrate intake with the risk of GC. Sixth, the quality of the included studies reflects the reliability of the conclusions made therein.

We were aware of several limitations of this meta-analysis. First, most of the included studies were retrospective case-control studies, which might have introduced potential selection and recall biases. Second, the cutoff values of nitrite and nitrate intakes differed among the included studies, which could have affected the comparability between exposure and control. Third, the significant heterogeneity could not be fully interpreted in the sensitivity and subgroup analyses. Fourth, the adjusted factors differed among the included studies, and these factors may have played an important role in the progression of GC. Fifth, publication bias is inevitable since this study was based on published articles.

Conclusions
===========

This study concluded that a high or moderate nitrite intake increases the risk of GC, whereas a high or moderate nitrate intake was associated with a decreased risk of GC. These associations are variable according to several characteristics of study or patients. Further large-scale prospective cohort studies are required to evaluate the correlation between nitrite or nitrate intake from various sources and the risk of GC.
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###### 

Baseline characteristic of studies included in the systematic review and meta-analysis.

  Study                                              Publication year   Study design         Country           Sample size   Age (years)   Percentage male (%)   Assessment of exposure   Reported outcomes     Adjusted factors                                                                                                                                                                                     NOS score
  -------------------------------------------------- ------------------ -------------------- ----------------- ------------- ------------- --------------------- ------------------------ --------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------
  Risch \[[@b22-medscimonit-25-1788]\]               1985               Case-control         Canada            492           35--79        66.3                  FFQ                      Nitrite and nitrate   Age, sex, and area of residence                                                                                                                                                                      7
  Buiatti \[[@b23-medscimonit-25-1788]\]             1990               Case-control         Italy             1,782         \<75          NA                    FFQ                      Nitrite and nitrate   Non-dietary variables and kilocalorie                                                                                                                                                                7
  Boeing \[[@b24-medscimonit-25-1788]\]              1991               Case-control         Germany           722           32--80        20.0--30.0            IAQ                      Nitrate               Age, sex and hospital                                                                                                                                                                                6
  Hansson \[[@b25-medscimonit-25-1788]\]             1994               Case-control         Sweden            1,017         40--79        64.4                  FFQ                      Nitrate               Age, gender, ascorbic acid, β-carotene, α-tocopherol                                                                                                                                                 7
  La Vecchia \[[@b26-medscimonit-25-1788]\]          1994               Case-control         Italy             2,747         19--74        59.4                  FFQ                      Nitrite and nitrate   age, sex, education, family history of gastric cancer, BMI, TEI                                                                                                                                      8
  Pobel \[[@b27-medscimonit-25-1788]\]               1995               Case-control         France            220           66.5          69.5                  FFQ                      Nitrite and nitrate   Age, sex, occupation and total calorie intake                                                                                                                                                        6
  La Vecchia \[[@b28-medscimonit-25-1788]\]          1997               Case-control         Italy             2,799         19--74        59.4                  FFQ                      Nitrite               Sex, age, and education                                                                                                                                                                              7
  van Loon \[[@b29-medscimonit-25-1788]\]            1998               Prospective cohort   The Netherlands   120,852       55--69        48.2                  FFQ                      Nitrite and nitrate   Age, sex, smoking, education, coffee consumption, intake of vitamin C and beta-carotene, family history of stomach cancer, prevalence of stomach disorders, use of refrigerator and use of freezer   8
  Galanis \[[@b30-medscimonit-25-1788]\]             1998               Prospective cohort   USA               11 907        \>18.0        47.1                  FFQ                      Nitrate               Age, education, Japanese place of birth, and gender. Analyses among men were also adjusted for cigarette and alcohol                                                                                 7
  De Stefani \[[@b31-medscimonit-25-1788]\]          1998               Case-control         France            1038          25--84        65.8                  FFQ                      Nitrite               Age, sex, residence, urban/rural status, smoking duration, alcohol consumption, and „mate" consumption                                                                                               6
  Knekt \[[@b32-medscimonit-25-1788]\]               1999               Prospective cohort   Finland           9985          15--99        52.8                  FFQ                      Nitrite and nitrate   Sex, age, municipality, smoking and TEI                                                                                                                                                              7
  Palli \[[@b33-medscimonit-25-1788]\]               2001               Case-control         Italy             943           All stages    60.1                  FFQ                      Nitrite and nitrate   Age, sex, social class, family history of gastric cancer, area of rural residence, BMI, total energy and each nutrient of interest                                                                   7
  Mayne \[[@b34-medscimonit-25-1788]\]               2001               Case-control         USA               1294          30--79        78.1                  IAQ                      Nitrite               Sex, site, age; race, proxy status, income, education, BMI, cigarettes/day, years of consuming beer, wine, and liquor, and TEI                                                                       7
  De Stefani \[[@b35-medscimonit-25-1788]\]          2001               Case-control         France            405           30--89        65.2                  FFQ                      Nitrite and nitrate   Age, gender, residence, urban/rural status, and education                                                                                                                                            6
  Engel \[[@b36-medscimonit-25-1788]\]               2003               Case-control         USA               1324          30--79        77.9                  IAQ                      Nitrite               Geographic center, age, sex, race, income, respondent type, TEI                                                                                                                                      7
  Lopez-Carrillo \[[@b37-medscimonit-25-1788]\]      2004               Case-control         Mexico            665           \>20          56.7                  FFQ                      Nitrite               Age, gender, residence, TEI, education, Hp/CagA status and ascorbic acid                                                                                                                             8
  Kim \[[@b38-medscimonit-25-1788]\]                 2007               Case-control         Korea             272           57.2          68.4                  FFQ                      Nitrate               Age, sex, socioeconomic status, refrigerator use, *H. pylori* infection, and foods                                                                                                                   7
  Ward \[[@b39-medscimonit-25-1788]\]                2008               Case-control         USA               400           \>21          NA                    IAQ                      Nitrite and nitrate   Year of birth, gender, education, smoking, alcohol, TEI, vitamin C, fiber, carbohydrate                                                                                                              6
  Hernández-Ramírez \[[@b40-medscimonit-25-1788]\]   2009               Case-control         Mexico            735           \>20          54.0                  FFQ                      Nitrite and nitrate   Energy, age, gender, *H. pylori* CagA status, schooling and consumptions of salt, chili and alcohol                                                                                                  7
  Loh \[[@b41-medscimonit-25-1788]\]                 2011               Prospective cohort   UK                23 363        40--79        46.2                  FFQ                      Nitrite               Age, sex, BMI, cigarette smoking status, alcohol intake, TEI, PI, educational, and menopausal status                                                                                                 8
  Cross \[[@b42-medscimonit-25-1788]\]               2011               Prospective cohort   France            494 979       50--71        59.7                  FFQ                      Nitrite and nitrate   Age, sex, BMI, education, ethnicity, tobacco smoking, alcohol drinking, PI, vigorous physical activity, and the daily intake of fruit, vegetables, saturated fat, and TEI                            8
  Navarro Silvera \[[@b43-medscimonit-25-1788]\]     2011               Case-control         USA               1294          30--79        NA                    IAQ                      Nitrite               Gender, age, site, race, income, education, proxy status, TEI, and mutual adjustment for other principle components                                                                                  7
  Keszei \[[@b44-medscimonit-25-1788]\]              2013               Prospective cohort   The Netherlands   120 852       55--69        48.2                  FFQ                      Nitrite and nitrate   Age, smoking status, TEI, BMI, alcoholic intake, vegetable intake, fruit intake, education, and PI                                                                                                   8
  Taneja \[[@b45-medscimonit-25-1788]\]              2017               Case-control         India             234           All stages    67.1                  IAQ                      Nitrate               Age, gender, and tobacco consumption                                                                                                                                                                 7

BMI -- body mass index; FFQ -- food-frequency questionnaire; IAQ -- interviewer-administered questionnaire; PI -- physical activity; TEI -- total energy intake.

###### 

Subgroup analyses for nitrite and nitrate intake and the risk of gastric cancer.

  Outcomes                             Factor             Groups              Number of studies   OR and 95% CI       P value   Heterogeneity (%)   P value for heterogeneity   P value between subgroups
  ------------------------------------ ------------------ ------------------- ------------------- ------------------- --------- ------------------- --------------------------- ---------------------------
  High versus low nitrite intake       Publication year   2000 or after       11                  1.28 (1.09--1.51)   0.003     67.2                0.001                       \<0.001
  Before 2000                          8                  1.18 (0.76--1.83)   0.462               94.5                \<0.001                                                   
  Study design                         Case-control       14                  1.38 (1.02--1.85)   0.034               92.2      \<0.001             0.588                       
  Cohort                               5                  1.04 (0.89--1.21)   0.633               39.8                0.156                                                     
  Country                              Europe             12                  1.11 (0.87--1.43)   0.402               91.2      \<0.001             \<0.001                     
  Other                                7                  1.56 (1.32--1.84)   \<0.001             22.4                0.259                                                     
  Percent male                         ≥60.0              7                   1.25 (0.78--2.02)   0.353               94.8      \<0.001             \<0.001                     
  \<60.0                               9                  1.18 (1.01--1.37)   0.032               61.2                0.008                                                     
  Assessment of exposure               FFQ                15                  1.18 (0.94--1.48)   0.150               90.2      \<0.001             \<0.001                     
  IAQ                                  4                  1.73 (1.22--2.44)   0.002               52.7                0.096                                                     
  Adjusted extent                      Fully              13                  1.23 (0.97--1.57)   0.091               91.1      \<0.001             \<0.001                     
  Partial                              6                  1.47 (1.20--1.79)   \<0.001             31.9                0.196                                                     
  Study quality                        High               15                  1.36 (1.18--1.56)   \<0.001             70.1      \<0.001             \<0.001                     
  Low                                  4                  0.83 (0.50--1.38)   0.466               67.6                0.026                                                     
  Moderate versus low nitrite intake   Publication year   2000 or after       10                  1.14 (0.97--1.34)   0.104     74.1                \<0.001                     0.265
  Before 2000                          5                  1.11 (0.99--1.23)   0.070               0.0                 0.593                                                     
  Study design                         Case-control       10                  1.23 (1.07--1.43)   0.005               46.9      0.049               \<0.001                     
  Cohort                               5                  0.98 (0.88--1.10)   0.744               42.7                0.137                                                     
  Country                              Europe             10                  1.04 (0.95--1.14)   0.375               43.5      0.068               \<0.001                     
  Other                                5                  1.30 (1.01--1.67)   0.045               53.5                0.072                                                     
  Percent male                         ≥60.0              4                   1.43 (1.16--1.77)   0.001               0.0       0.407               \<0.001                     
  \<60.0                               8                  0.99 (0.92--1.05)   0.672               7.1                 0.376                                                     
  Assessment of exposure               FFQ                12                  1.03 (0.95--1.12)   0.414               31.6      0.139               \<0.001                     
  IAQ                                  3                  1.56 (1.27--1.93)   \<0.001             14.6                0.310                                                     
  Adjusted extent                      Fully              11                  1.11 (0.97--1.26)   0.127               69.9      \<0.001             0.078                       
  Partial                              4                  1.20 (1.02--1.40)   0.025               0.0                 0.479                                                     
  Study quality                        High               12                  1.13 (1.00--1.27)   0.044               70.1      \<0.001             0.759                       
  Low                                  3                  1.11 (0.76--1.61)   0.583               0.0                 0.375                                                     
  High versus low nitrate intake       Publication year   2000 or after       8                   0.89 (0.73--1.09)   0.268     61.3                0.011                       \<0.001
  Before 2000                          9                  0.75 (0.60--0.93)   0.010               59.1                0.012                                                     
  Study design                         Case-control       12                  0.79 (0.63--1.01)   0.058               83.1      \<0.001             0.599                       
  Cohort                               5                  0.92 (0.77--1.09)   0.321               0.0                 0.745                                                     
  Country                              Europe             11                  0.78 (0.64--0.95)   0.015               59.3      0.006               \<0.001                     
  Other                                6                  0.88 (0.65--1.21)   0.444               82.2                \<0.001                                                   
  Percent male                         ≥60.0              7                   0.81 (0.61--1.08)   0.148               80.3      \<0.001             0.002                       
  \<60.0                               8                  0.77 (0.58--1.01)   0.055               68.6                0.002                                                     
  Assessment of exposure               FFQ                14                  0.75 (0.64--0.88)   \<0.001             51.3      0.014               \<0.001                     
  IAQ                                  3                  1.10 (1.03--1.19)   0.008               0.0                 0.633                                                     
  Adjusted extent                      Fully              9                   0.78 (0.61--1.02)   0.065               68.0      0.002               \<0.001                     
  Partial                              8                  0.85 (0.68--1.08)   0.179               74.6                \<0.001                                                   
  Study quality                        High               12                  0.75 (0.63--0.89)   0.001               58.7      0.005               \<0.001                     
  Low                                  5                  1.07 (0.94--1.23)   0.304               6.2                 0.371                                                     
  Moderate versus low nitrate intake   Publication year   2000 or after       7                   0.94 (0.84--1.05)   0.294     0.0                 0.486                       0.003
  Before 2000                          8                  0.80 (0.65--0.98)   0.032               75.8                \<0.001                                                   
  Study design                         Case-control       10                  0.80 (0.66--0.96)   0.018               66.8      0.001               \<0.001                     
  Cohort                               5                  0.96 (0.86--1.08)   0.512               0.0                 0.517                                                     
  Country                              Europe             11                  0.81 (0.70--0.94)   0.006               71.2      \<0.001             0.008                       
  Other                                4                  1.13 (0.89--1.45)   0.324               0.0                 0.671                                                     
  Percent male                         ≥60.0              5                   0.82 (0.67--1.02)   0.069               10.8      0.344               0.679                       
  \<60.0                               8                  0.86 (0.70--1.07)   0.170               80.2                \<0.001                                                   
  Assessment of exposure               FFQ                13                  0.85 (0.74--0.99)   0.037               69.8      \<0.001             0.587                       
  IAQ                                  2                  0.95 (0.54--1.67)   0.853               69.2                0.072                                                     
  Adjusted extent                      Fully              9                   0.91 (0.73--1.13)   0.387               79.9      \<0.001             0.883                       
  Partial                              6                  0.83 (0.74--0.93)   0.002               0.0                 0.632                                                     
  Study quality                        High               11                  0.86 (0.74--1.01)   0.065               73.1      \<0.001             0.786                       
  Low                                  4                  0.85 (0.59--1.23)   0.389               49.5                0.115                                                     

CI -- confidence interval; FFQ -- food-frequency questionnaire; IAQ -- interviewer-administered questionnaire; OR -- odds ratio.
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